• 검색 결과가 없습니다.

첫째, 맞춤형 정보제공의 목적이 만성질환 관리의 일환임을 고려할 때, 3~6개월 단위의 정보 업데이트가 필요하다. 둘째, 정보제공 방식이 환자 스 스로 개인정보를 입력하여야 가능하므로 환자가 건강보험심사평가 홈페이지 또는 애플리케이션 접근하도록 유도하는 방안을 고안하여야 한다(예: 의료기 관을 통한 안내, TV 홍보). 셋째, 만성질환자는 대체로 연령대가 높기 때문에 지표의 개념이나 수치값에 대한 이해도가 낮다. 요약된 투약정보를 효과적인 전달하기 위해서는 도표․그림문자를 이용한 표현방식의 개발도 중요한 사 항이다. 넷째, 혈압강하제 4성분군 이상 사용비율, 권장되지 않는 병용요법 사용비율 등 임상지침에 근거한 투약정보로 확대할 수 있다. 마지막으로 효 과 평가를 위해 심·뇌혈관질환 고위험군 등록관리사업과 같이 시범지역에의 우선 제공을 고려해볼 수 있다.

참고문헌

건강보험심사평가원. 의약품의 안정하고 적정한 사용을 위한 의약품처방조제 지원서비스. 서울;건강보험심사평가원:2011.

건강보험심사평가원. 2011 상반기 고혈압 적정성 평가결과. 서울:건강보험심 사평가원;2011.

건강정책학회. 만성질환관리, 무엇이 문제인가? 건강정책학회 춘계학술대회 토론회. 2010.

국민건강보험공단. 2009년 지역별의료이용통계. 서울:국민건강보험공단;2010.

김동숙, 장수현, 배승진, 이병란, 최혜린. 약제심사제도 선진화 방안 연구 - DUR제도 발전방안을 중심으로. 서울:건강보험심사평가원;2010.

김윤, 배재봉, 김혜령, 김선영, 심동현, 황인정 등. PHR 현황 분석서. 서 울:EHR 사업단;2008.

김재용, 박현태, 강희설, 이선희, 김화영, 임지혜 등. 우리나라의 만성질병관 리체계 구축방안 연구. 서울:건강보험심사평가원;2007.

김진현, 곽미영, 김은주, 권창익, 김윤. 소비자 특성별 PHR을 이용한 평생건 강관리서비스 이용행태 : 소비자 수요도 조사. 대한의료정보학회지.

2008;14(4):329-343.

박찬미. 치료지속성에 따른 의료비용 및 건강결과 분석 - 고혈압, 당뇨를 중 심으로. 서울:건강보험심사평가원;2010.

방송통신위원회, 한국인터넷진흥원. 2011년 하반기 스마트폰이용실태조사. 2012.

신현택. 전산화 DUR시스템을 통한 국민건강보험 약제비심사 효율성 샹상방 안에 대한 연구. 서울:숙명여자대학교 의약정보연구소;2003.

안무업, 최기훈. 원격진료, 이헬스 및 유헬스로의 발전과정. 대한의사협회지.

2009;52(12):1131-1140.

전기홍. 건강관리서비스와 만성질환 예방서비스. 대한의사협회지.

2009;52(4):322-325.

한국데이터베이스진흥센터. 공공정보 상업적 활용의 경제적 가치측정 및 파 급효과 분석 연구. 서울:한국데이터베이스진흥센터;2006.

허순임, 신호성, 강민아, 김태일, 김창보. 건강보험 적정 보장성 확보방안. 서 울:한국보건사회연구원;2007.

홍재석. 당뇨병 환자의 약제처방현황과 투약 순응도 분석. 서울:건강보험심사 평가원;2009.

홍재석, 김재용, 이은미. 만성질환 적정관리현황 평가방안 연구. 서울:건강보 험심사평가원;2008.

Adelufosi AO, Adebowale TO, Abayomi O, Mosanya JT. Medication adherence and quality of life among Nigerian outpatients with schizophrenia.

Gen Hosp Psychiatry 2012;34(1):72-9.

Adewuya AO, Owoeye OA, Erinfolami AR, Coker AO, Ogun OC, Okewole AO, et al. Prevalence and correlates of poor medication adherence amongst psychiatric outpatients in southwestern Nigeria. Gen Hosp Psychiatry 2009;31(2):167-74.

Ágh T, Inotai A, Mészáros Á. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease. Respiration 2011;82(4):328-34.

Al-Qazaz HKh, Sulaiman SA, Hassali MA, Shafie AA, Sundram S, Al-Nuri R, et al. Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes. Int J Clin Pharm 2011;33(6):

1028-35.

Amado Guirado E, Pujol Ribera E, Pacheco Huergo V, Borras JM.

Knowledge and adherence to antihypertensive therapy in primary care:

results of a randomized trial. Gac Sanit 2011;25(1):62-7.

Arena C, Morin AS, Blanchon T, Hanslik T, Cabane J, Dupuy A, et al.

Impact of glucocorticoid-induced adverse events on adherence in patients receiving long-term systemic glucocorticoid therapy. Br J Dermatol 2010;163(4):832-7.

Baena-Díez JM, Gómez-Fernández C, Vilató-García M, Vásquez-Lazo EJ, Byram AO, Vidal-Solsona M. A prescription register incorporated into computerized medical records for patients with hypertension: a new instrument to evaluate medication adherence. Aten Primaria 2011;43(7):

336-42.

Barnestein-Fonseca P, Leiva-Fernández J, Vidal-España F, García-Ruiz A, Prados-Torres D, Leiva-Fernández F. Is it possible to diagnose the therapeutic adherence of patients with COPD in clinical practice? A cohort study. BMC Pulm Med 2011;11:6

Bates JA, Whitehead R, Bolge SC, Kim E. Correlates of medication adherence among patients with bipolar disorder: results of the bipolar evaluation of satisfaction and tolerability (BEST) study: a nationwide cross-sectional survey. Prim Care Companion J Clin Psychiatry 2010;12(5).

Bermingham M, Hayden J, Dawkins I, Miwa S, Gibson D, McDonald K, et al. Prospective analysis of LDL-C goal achievement and self-reported medication adherence among statin users in primary care.

Clin Ther 2011;33(9):1180-9.

Berni A, Ciani E, Cecioni I, Poggesi L, Abbate R, Boddi M. Adherence to antihypertensive therapy affects Ambulatory Arterial Stiffness Index.

Eur J Intern Med 2011;22(1):93-8.

Berry SD, Quach L, Procter-Gray E, Kiel DP, Li W, Samelson EJ, et al.

Poor adherence to medications may be associated with falls. J Gerontol A Biol Sci Med Sci 2010;65(5):553-8.

Bharmal M, Payne K, Atkinson MJ, Desrosiers MP, Morisky DE, Gemmen E. Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications.

Health Qual Life Outcomes 2009;7:36

Bozek A, Jarzab J. Adherence to asthma therapy in elderly patients. J Asthma 2010;47(2):162-5.

Breuil V, Cortet B, Cotté FE, Arnould B, Dias-Barbosa C, Gaudin AF, et al. Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women. Osteoporos Int 2012;23(2):445-55.

Carbonell Abella C, Guañabens Gay N, Regadera Anechina L, Marín Rives JA, Taverna Llauradó E, Ayechu Redín MP. Analysis of therapeutic compliance in women with osteoporosis. Reumatol Clin. 2011;7(5):299-304.

Cardoso L, Miasso AI, Galera SA, Maia BM, Esteves RB. Adherence level and knowledge about psychopharmacological treatment among patients discharged from psychiatric internment. Rev Lat Am Enfermagem 2011;19(5):1146-54.

Caro JJ, Payne K. Real-world effectiveness of antihypertensive drugs.

Canadian Medical Association Journal 2000; 162:190–191.

Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999;37(9):846-57.

Chou PL, Rau KM, Lin CC. Development and psychometric testing of a short version of the Barriers Questionnaire-Taiwan form for cancer patients. Int J Nurs Stud 2011;48(9):1071-9.

Cornélio Rde C, Pinto AL, Pace FH, Moraes JP, Chebli JM. Non-adherence to the therapy in Crohn's disease patients: prevalence and risk factors.

Arq Gastroenterol 2009;46(3):183-9.

Criswell TJ, Weber CA, Xu Y, Carter BL. Effect of self-efficacy and social support on adherence to antihypertensive drugs. Pharmacotherapy 2010;30(5):432-41.

Daley DJ, Deane KH, Gray RJ, Worth PF, Clark AB, Sabanathan K, et al.

The use of carer assisted adherence therapy for people with Parkinson's disease and their carers (CAAT-PARK): study protocol for a randomised controlled trial. Trials 2011;12:251.

Dal-Paz K, Moraes-Filho JP, Navarro-Rodriguez T, Eisig JN, Barbuti R, Quigley EM. Low levels of adherence with proton pump inhibitor therapy contribute to therapeutic failure in gastroesophageal reflux disease. Dis Esophagus 2011.

de Castro RA, Aliti GB, Linhares JC, Rabelo ER. Adherence of patients with heart failure to treatment in a teaching hospital. Rev Gaucha Enferm 2010;31(2):225-31.

Díez A, Carbonell C, Calaf J, Caloto MT, Nocea G. Observational study of treatment compliance in women initiating antiresorptive therapy with or without calcium and vitamin D supplements in Spain. Menopause 2012;19(1):89-95.

Dosse C, Cesarino CB, Martin JF, Castedo MC. Factors associated to patients' noncompliance with hypertension treatment. Rev Lat Am Enfermagem 2009;17(2):201-6.

Epilepsy Behav 2011;21(4):467-72.

Esmerio FG, Souza EN, Leiria TL, Lunelli R, Moraes MA. Constant use of oral anticoagulants: implications in the control of their adequate levels.

Arq Bras Cardiol 2009;93(5):549-54.

Fincham JE. Patient Compliance with Medications - Issues and Opportunities, Fincham J.E. edit. Pharmaceutical Products Press. Binghamton, NY;2007.

Foster JM, Smith L, Bosnic-Anticevich SZ, Usherwood T, Sawyer SM, Rand CS, et al. IDENTIFYING PATIENT-SPECIFIC BELIEFS AND BEHAVIOURS FOR CONVERSATIONS ABOUT ADHERENCE IN ASTHMA. ntern Med J 2011.

Garber MC, Nau DP, Erinkson SR, et al. The concordance if self-report with other measures of medication adherence: a summary of the literature. Med Care 2004;42(7):649-52. Review.

Gatti ME, Jacobson KL, Gazmararian JA, Schmotzer B, Kripalani S.

Relationships between beliefs about medications and adherence. Am J Health Syst Pharm 2009;66(7):657-64.

Giraud V, Allaert FA, Roche N. Inhaler technique and asthma: feasability and acceptability of training by pharmacists. Respir Med 2011;105(12):1815-22.

Giraud V, Allaert FA. Improved asthma control with breath-actuated pressurized metered dose inhaler (pMDI): the SYSTER survey. Eur Rev Med Pharmacol Sci 2009;13(5):323-30.

Greenhalgh T, Wood GW, Bratan T, Stramer K, Hinder S. Patients’

attitudes to the summary care record and HealthSpace: qualitative study.

BMJ 2008;336:1290.

Grymonpre R, Cheang M, Fraser M, Metge C, Sitar DS. Validity of a prescription claims database to estimate medication adherence in order persons. Med Care 2006;44(5):471-7.

Gutiérrez-Angulo ML, Lopetegi-Uranga P, Sánchez-Martín I, Garaigordobil- Landazabal M. Therapeutic compliance in patients with arterial hypertension and type 2 diabetes mellitus. Rev Calid Asist 2011.

Haynes RB. Determinants of compliance: The disease and the mechanics of treatment. Baltimore MD, Johns Hopkins University Press;1979.

Hentinen M.(1987). Hoitoon sitoutuminen. [Adherence to treatment.] Pro Nursing Vuosikirja [Pro Nursing Annual Book]. Julkaisusarja A 1 [Publication Series A 1]:78–82.

Hodgkins P, Swinburn P, Solomon D, Yen L, Dewilde S, Lloyd A. Patient Preferences for First-Line Oral Treatment for Mild-to-Moderate Ulcerative Colitis: A Discrete-Choice Experiment. Patient. 2011.

Holt EW, Muntner P, Joyce CJ, Webber L, Krousel-Wood MA. Health- related quality of life and antihypertensive medication adherence among older adults. Age Ageing 2010;39(4):481-7.

Huas D, Debiais F, Blotman F, Cortet B, Mercier F, Rousseaux C, et al.

Compliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatment. BMC Womens Health 2010;10:26.

Hypertension Detection and Follow-up Program Cooperative Group.

Five-year findings of the hypertension detection and follow-up program.I.

Reduction in mortality of persons with high blood pressure, including mild hypertension. Journal of the American Medical Association 1979;

242:2562–2571.

Jamous RM, Sweileh WM, Abu-Taha AS, Sawalha AF, Zyoud SH, Morisky DE. Adherence and satisfaction with oral hypoglycemic medications: a pilot study in Palestine. Int J Clin Pharm 2011;33(6):942-8.

Jansà M, Hernández C, Vidal M, Nuñez M, Bertran MJ, Sanz S, et al.

Multidimensional analysis of treatment adherence in patients with multiple chronic conditions. A cross-sectional study in a tertiary hospital. Patient Educ Couns 2010;81(2):161-8.

Jönsson S, Olsson B, Söderberg J, Wadenvik H. Good adherence to imatinib therapy among patients with chronic myeloid leukemia-a single-center observational study. Ann Hematol 2011.

Kardas P. Prevalence of non-adherence to medication among patients treated for selected chronic conditions. Pol Merkur Lekarski. 2011;31(184) :215-20.

Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care 2008;46(11):1125-33.

Khdour MR, Kidney JC, Smyth BM, McElnay JC. Clinical pharmacy-led disease and medicine management programme for patients with COPD. Br J Clin Pharmacol 2009;68(4):588-98.

Kim E, Gupta S, Bolge S, Chen CC, Whitehead R, Bates JA. Adherence and outcomes associated with copayment burden in schizophrenia: a cross-sectional survey. J Med Econ 2010;13(2):185-92.

Kim MI, Johnson KB. Personal Health Records: Evaluation of Functionality and Utility. Journal of the American Medical Informatics Association.

2002;9(2):171-180.

Kirkegaard P, Edwards AG, Hansen B, Hansen MD, Jensen MS, Lauritzen T, et al. The RISAP-study: a complex intervention in risk communication and shared decision-making in general practice. BMC Fam Pract 2010;11:70.

Kitzinger J. Qualitative Research: Introducing focus groups. BMJ 1995;311 (7000): 299–302.

Kripalani S, Risser J, Gatti ME, Jacobson TA. Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low- literacy patients with chronic disease. Value Health 2009;12(1):118-23.

Krousel-Wood M, Islam T, Muntner P, Holt E, Joyce C, Morisky DE, et al. Association of depression with antihypertensive medication adherence in older adults: cross-sectional and longitudinal findings from CoSMO.

Ann Behav Med 2010;40(3):248-57.

Krousel-Wood M, Joyce C, Holt E, Muntner P, Webber LS, Morisky DE, et al. Predictors of decline in medication adherence: results from the cohort study of medication adherence among older adults. Hypertension 2011;58(5):804-10.

Krousel-Wood MA, Muntner P, Joyce CJ, Islam T, Stanley E, Holt EW, et al. Adverse effects of complementary and alternative medicine on antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc 2010;58(1):54-61.

Langley PC, Ruiz-Iban MA, Molina JT, De Andres J, Castellón JR. The prevalence, correlates and treatment of pain in Spain. J Med Econ 2011;14(3):367-80.

Lau R, Stewart K, McNamara KP, Jackson SL, Hughes JD, Peterson GM, et al. Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial. BMC Health Serv Res 2010;10:34.

Li S, He A, Yang J, Yin T, Xu W. A logistic regression analysis of factors related to the treatment compliance of infertile patients with polycystic ovary syndrome. J Reprod Med 2011;56(7-8):325-32.

Mackey K, Parchman ML, Leykum LK, Lanham HJ, Noël PH, Zeber JE.

Impact of the Chronic Care Model on medication adherence when patients perceive cost as a barrier. Prim Care Diabetes 2012.

Mann DM, Ponieman D, Leventhal H, Halm EA. Predictors of adherence to diabetes medications: the role of disease and medication beliefs. J Behav Med 2009;32(3):278-84.

Miasso AI, Monteschi M, Giacchero KG. Bipolar affective disorder:

medication adherence and satisfaction with treatment and guidance by the health team in a mental health service. Rev Lat Am Enfermagem 2009;17(4):548-56.

Morisky DE, Levine DM, Green LW et al. Five year blood pressure control and mortality following health education for hypertensive patients. American Journal of Public Health 1963; 73:153–162.

Morisky DE, Green LW, Levine DM. Concurrent and Predictive Validity of a Self-Reported Measure of Medication Adherence. Medical Care.

1986;24(1):67-74.

Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive Validity of a Medication Adherence Measure in an Outpatient Setting. Journal of Clinical Hypertenssion. 2008;10:348-354.

Muntner P, Joyce C, Holt E, He J, Morisky D, Webber LS, et al. Defining the minimal detectable change in scores on the eight-item Morisky Medication Adherence Scale. Ann Pharmacother 2011;45(5):569-75.

Muntner P, Mann DM, Woodward M, Choi JW, Stoler RC, Shimbo D, et al. Predictors of low clopidogrel adherence following percutaneous coronary intervention. Am J Cardiol 2011;108(6):822-7.

Nakhutina L, Gonzalez JS, Margolis SA, Spada A, Grant A. Adherence to antiepileptic drugs and beliefs about medication among predominantly ethnic minority patients with epilepsy. Epilepsy Behav 2011;22(3):584-6.

Nicolino PS, Vedana KG, Miasso AI, Cardoso L, Galera SA. Schizophrenia:

adherence to treatment and beliefs about the disorder and the drug treatment. Rev Esc Enferm USP 2011;45(3):708-15.

Obreli-Neto PR, Guidoni CM, de Oliveira Baldoni A, Pilger D, Cruciol-Souza JM, Gaeti-Franco WP, et al. Effect of a 36-month pharmaceutical care program on pharmacotherapy adherence in elderly diabetic and hypertensive patients. Int J Clin Pharm 2011;33(4):642-9.

OECD. Health at a Glance 2011 OECD Indicators. 2011.

Ortega Suárez FJ, Sánchez Plumed J, Pérez Valentín MA, Pereira Palomo P, Muñoz Cepeda MA, Lorenzo Aguiar D; Grupo de Estudio Vatren.

Validation on the simplified medication adherence questionnaire (SMAQ) in renal transplant patients on tacrolimus.Nefrologia. 2011;31(6):690-6.

Oscanoa TJ. Diagnosis of drug-related problems in elderly patients at the time of hospitalization. Rev Peru Med Exp Salud Publica 2011;28(2):256-63.

Osterberg L, Blaschke T. Adherence to Medication. N Engl J Med 2005;353:487-497.

Palacios S, Sánchez-Borrego R, Neyro JL, Quereda F, Vázquez F, Pérez M, et al. Knowledge and compliance from patients with postmenopausal osteoporosis treatment. Menopause Int 2009;15(3):113-9.

Pérez Bermejo JM, Pérez Valverde AI, Ureña Ramírez I, Hervás Mohíno MD, García Muñoz C, Arcediano García-Sacedón P. Adherence to the treatment in the old people. Rev Enferm 2010;33(4):16-20.

Prospective studies collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet 1995; 346:1647–1653.

Quadros AS, Welter DI, Camozzatto FO, Chaves A, Mehta RH, Gottschall CA, et al. Identifying patients at risk for premature discontinuation of thienopyridine after coronary stent implantation. Am J Cardiol 2011;107(5) :685-9.

Rand CS. Measuring adherence with therapy for chronic diseases:

implications for the treatment of heterozygous familial hypercholesterolemia.

American Journal of Cardiology 1993;72(10):D68-D74.

Ribera M, Daudén E, Puig L, Briones VG, Herranz JM, Bordas X, et al.

Design and validation of a questionnaire to measure treatment satisfaction in patients with moderate-to-severe psoriasis: the NEODERMA study.

Actas Dermosifiliogr 2011;102(1):28-38.

Ruiz MA, Heras F, Alomar A, Conde-Salazar L, de la Cuadra J, Serra E, et al. Development and validation of a questionnaire on 'Satisfaction with dermatological treatment of hand eczema' (DermaSat). Health Qual Life Outcomes 2010;8:127.

Sáez de la Fuente J, Granja Berná V, Lechuga Vázquez P, Otero Perpiña B, Herreros de Tejada López-Coterilla A, Medina Asensio J. Efficiency of the information given at discharge and adherence of polymedicated patients. Farm Hosp 2011;35(3):128-34.

Sakthong P, Chabunthom R, Charoenvisuthiwongs R. Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes. Ann Pharmacother 2009;43(5):950-7.

Sakthong P, Chabunthom R, Charoenvisuthiwongs R. Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes. Ann Pharmacother 2009;43(5):950-7.